SOX9 predicts progression of liver fibrosis in patients with chronic hepatitis C

被引:0
|
作者
Athwal, Varinder S. [1 ,2 ]
Pritchett, James [1 ,3 ]
Zaitoun, Abed [4 ,6 ]
Irving, William [5 ,6 ]
Guha, Indra Neil [6 ,7 ]
Hanley, Neil [1 ,8 ]
Hanley, Karen Piper [1 ]
机构
[1] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Manchester, Lancs, England
[2] Univ Hosp South Manchester, Dept Gastroenterol, Manchester, Lancs, England
[3] Manchester Metropolitan Univ, Healthcare Sci, Manchester, Lancs, England
[4] Univ Nottingham Hosp, Dept Histopathol, Nottingham, England
[5] Nottingham Univ Hopsitals NHS Trust, Dept Microbiol, Nottingham, England
[6] Univ Nottingham, NIHR BRU Gastroenterol & Hepatol, Nottingham, England
[7] Nottingham Univ Hosp NHS Trust, Dept Gastroenterol & Hepatol, Nottingham, England
[8] Cent Manchester NHS Fdn Trust, Res & Innovat Dept, Manchester, Lancs, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
435
引用
收藏
页码:239A / 239A
页数:1
相关论文
共 50 条
  • [1] SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
    Athwal, Varinder S.
    Pritchett, James
    Llewellyn, Jessica
    Martin, Katherine
    Camacho, Elizabeth
    Raza, Sayyid M. A.
    Phythian-Adams, Alexander
    Birchall, Lindsay J.
    Mullan, Aoibheann F.
    Su, Kim
    Pearmain, Laurence
    Dolman, Grace
    Zaitoun, Abed M.
    Friedman, Scott L.
    MacDonald, Andrew
    Irving, William L.
    Guha, Indra N.
    Hanley, Neil A.
    Hanley, Karen Piper
    EMBO MOLECULAR MEDICINE, 2017, 9 (12) : 1696 - 1710
  • [2] The Cirrhosis Risk Score Predicts Liver Fibrosis Progression in Patients with Initially Mild Chronic Hepatitis C
    Pradat, Pierre
    Trepo, Eric
    Potthoff, Andrej
    Bakshi, Rakesh
    Young, Bradford
    Trepo, Christian
    Lagier, Robert
    Moreno, Christophe
    Lemmers, Arnaud
    Gustot, Thierry
    Degre, Delphine
    Adler, Michael
    Wedemeyer, Heiner
    HEPATOLOGY, 2010, 51 (01) : 356 - 357
  • [3] Natural history of liver fibrosis progression in patients with chronic hepatitis C
    Poynard, T
    Bedossa, P
    Opolon, P
    LANCET, 1997, 349 (9055): : 825 - 832
  • [4] Natural history of liver fibrosis progression in patients with chronic hepatitis C
    Franke, A
    Zeuzem, S
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1998, 36 (06): : 539 - 541
  • [5] SOX9 in biliary atresia: New insight for fibrosis progression
    Hanaa Ahmed El-Araby
    Magdy Anwar Saber
    Noha Mohamed Radwan
    Doha Maher Taie
    Nermin Mohamed Adawy
    Ahmad Mohamed Sira
    Hepatobiliary & Pancreatic Diseases International, 2021, 20 (02) : 154 - 162
  • [6] SOX9 in biliary atresia: New insight for fibrosis progression
    El-Araby, Hanaa Ahmed
    Saber, Magdy Anwar
    Radwan, Noha Mohamed
    Taie, Doha Maher
    Adawy, Nermin Mohamed
    Sira, Ahmad Mohamed
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (02) : 154 - 162
  • [7] Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans
    Pritchett, James
    Harvey, Emma
    Athwal, Varinder
    Berry, Andrew
    Rowe, Cliff
    Oakley, Fiona
    Moles, Anna
    Mann, Derek A.
    Bobola, Nicoletta
    Sharrocks, Andrew D.
    Thomson, Brian J.
    Zaitoun, Abed M.
    Irving, William L.
    Guha, Indra N.
    Hanley, Neil A.
    Hanley, Karen Piper
    HEPATOLOGY, 2012, 56 (03) : 1108 - 1116
  • [8] SOX9 contributes to the progression of ductular reaction for the protection from chronic liver injury
    Daiki Yoshii
    Keita Shimata
    Yuji Yokouchi
    Yoshihiro Komohara
    Hiroko Suda
    Masaki Honda
    Kenichi Yamamura
    Taizo Hibi
    Yukihiro Inomata
    Human Cell, 2022, 35 : 721 - 734
  • [9] SOX9 contributes to the progression of ductular reaction for the protection from chronic liver injury
    Yoshii, Daiki
    Shimata, Keita
    Yokouchi, Yuji
    Komohara, Yoshihiro
    Suda, Hiroko
    Honda, Masaki
    Yamamura, Kenichi
    Hibi, Taizo
    Inomata, Yukihiro
    HUMAN CELL, 2022, 35 (02) : 721 - 734
  • [10] Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation
    Chopra, KB
    Demetris, AJ
    Blakolmer, K
    Dvorchik, I
    Laskus, T
    Wang, LF
    Araya, VR
    Dodson, F
    Fung, JJ
    Rakela, J
    Vargas, HE
    TRANSPLANTATION, 2003, 76 (10) : 1487 - 1491